ZENITHDRUG
Start SIP
Invest Now
Start SIP in ZENITHDRUG
Performance
- Low
- ₹47
- High
- ₹48
- 52 Week Low
- ₹45
- 52 Week High
- ₹107
- Open Price₹48
- Previous Close₹48
- Volume6,400
- 50 DMA₹50.43
- 100 DMA₹54.53
- 200 DMA₹61.07
Investment Returns
- Over 1 Month -4.96%
- Over 3 Month -19.97%
- Over 6 Month -38.17%
- Over 1 Year -36.79%
Smart Investing Starts Here Start SIP with Zenith Drugs for Steady Growth!
Zenith Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.2
- PEG Ratio
- -
- Market Cap Cr
- 80
- P/B Ratio
- 1.1
- Average True Range
- 2.7
- EPS
- 4.26
- Dividend Yield
- 0
- MACD Signal
- -0.73
- RSI
- 43.85
- MFI
- 60.13
Zenith Drugs Financials
Zenith Drugs Technicals
EMA & SMA
Current Price
₹46.90
-0.8
(-1.68%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹48.41
- 50 Day
- ₹50.43
- 100 Day
- ₹54.53
- 200 Day
- ₹61.07
Resistance and Support
47.27
- R3 48.73
- R2 48.37
- R1 47.63
- S1 46.53
- S2 46.17
- S3 45.43
Zenith Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-05-29 | Audited Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-04-17 | To consider Fund Raising & Others | To consider Other business matters. (Revised) Final Dividend of Re. 0.5 per equity share |
| 2024-11-14 | Quarterly Results | |
| 2024-05-29 | Audited Results |
Zenith Drugs F&O
About Zenith Drugs
- NSE Symbol
- ZENITHDRUG
- BSE Symbol
- Managing Director
- Mr. Sandeep Bhardwaj
- ISIN
- INE0QWN01013
Similar Stocks to Zenith Drugs
Zenith Drugs FAQs
Zenith Drugs share price is ₹46 As on 22 February, 2026 | 03:30
The Market Cap of Zenith Drugs is ₹80.4 Cr As on 22 February, 2026 | 03:30
The P/E ratio of Zenith Drugs is 11.2 As on 22 February, 2026 | 03:30
The PB ratio of Zenith Drugs is 1.1 As on 22 February, 2026 | 03:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.